SCHEMBL5268504

SCHEMBL5268504

CC(NCc1cccc(OCc2ccccc2)c1)c1ccc(F)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.60
MEN1 O00255 4/20 0.60
BCHE P06276 5/20 0.57
ALDH1A1 P00352 3/20 0.53
MAPT P10636 2/20 0.53
THRB P10828 2/20 0.53
PKM P14618 2/20 0.53
RAB9A P51151 2/20 0.53
BLM P54132 2/20 0.53
L3MBTL1 Q9Y468 2/20 0.53
TDP1 Q9NUW8 2/20 0.53
LMNA P02545 1/20 0.53
RECQL P46063 1/20 0.53
CASP6 P55212 1/20 0.53
KDM4E B2RXH2 3/20 0.53
CASR P41180 1/20 0.52
SMN1; SMN2 Q16637 2/20 0.52
MAOB P27338 1/20 0.50
ACACB O00763 1/20 0.48
GAA P10253 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5267428 0.91 MEN1 (0.70) KMT2AMEN1BCHEALDH1A1MAPT
SCHEMBL5267733 0.91 MEN1 (0.70) KMT2AMEN1BCHEALDH1A1MAPT
SCHEMBL5270940 0.90 MEN1 (0.62) KMT2AMEN1BCHEALDH1A1MAPT
SCHEMBL5268578 0.89 KMT2A (0.62) KMT2AMEN1BCHECASRMAOB
SCHEMBL5267222 0.89 MEN1 (0.61) KMT2AMEN1BCHEALDH1A1MAPT
SCHEMBL5267631 0.88 CASR (0.62) KMT2AMEN1BCHEALDH1A1TDP1
SCHEMBL5266218 0.88 MEN1 (0.60) KMT2AMEN1BCHEALDH1A1MAPT
SCHEMBL5272357 0.88 MEN1 (0.60) KMT2AMEN1BCHEALDH1A1MAPT
SCHEMBL5270611 0.87 BCHE (0.59) KMT2AMEN1BCHEALDH1A1MAPT
SCHEMBL5269238 0.85 MEN1 (0.60) KMT2AMEN1BCHEALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1074539-B1 Process for producing optically active 3,3,3,-trifluoro-2-hydroxy-2-methylpropionic acid, and salt thereof SUMITOMO CHEMICAL CO (JP) 2007-10-17 EP disclosed
US-6894190-B2 Process for producing optically active 3,3,3-trifluoro-2-hydroxy-2-methylpropionic acid, and salt thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2005-05-17 US disclosed
US-6653507-B2 Useful intermediate compound of pharmaceuticals for urinary incontinence SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2003-11-25 US disclosed
US-20020143212-A1 Process for producing optically active 3,3,3-trifluoro-2-hydroxy-2-methylpropionic acid, and salt thereof SUMITOMO CHEMICAL COMPANY, LIMITED 2002-10-03 US disclosed
US-6403832-B1 MIXING ACID WITH AMINE, PRECIPITATING SALT, AND FILTERING; GOOD OPTICAL PURITY SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2002-06-11 US disclosed
EP-1074539-A2 Process for producing optically active 3,3,3,-trifluoro-2-hydroxy-2-methylpropionic acid, and salt thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2001-02-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020143212-A1 Process for producing optically active 3,3,3-trifluoro-2-hydroxy-2-methylpropionic acid, and salt thereof ALDH1A2, ALDH7A1, ALDH18A1 KMT2A 1610/4885MEN1 467/4885BCHE 2684/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.